Skip to content

Conditioned Pain Modulation in Chronic Neck Pain Patients

The Hypersensitivity and Changes of Conditioned Pain Modulation in Chronic Neck Pain Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03362203
Enrollment
30
Registered
2017-12-05
Start date
2018-01-01
Completion date
2018-08-01
Last updated
2017-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neck Pain

Keywords

Conditioned pain modulation, neck pain

Brief summary

The aim of this study was to evaluate changes in local and segmental hypersensitivity and endogenous pain inhibition in people with chronic nonspecific neck pain.

Detailed description

Quantitative sensory testing is widely used in human research to investigate the state of the peripheral and central nervous system contributions in pain processing. It is a valuable tool to help identify central sensitization and may be important in the treatment of chronic neck pain. This study is a cross-sectional study. Two groups including chronic neck pain group and healthy volunteers group will be arranged in this study. The healthy subjects will be matched for sex and age in relation to the neck pain group. The pressure pain threshold (PPT) will be measured at the neck muscle in both groups. The cold pressor test will be used in both groups to activate conditioned pain modulation.

Interventions

OTHERPatients with chronic neck pain

Patients,aged 21-80 years, must have experienced neck pain for at least 3 months and have reported a minimal pain level of 30 (pain threshold) on the 0-100 pain numerical rating scale (NRS) in the last 7 days.

OTHERSubjects without chronic neck pain

Subjects,aged 21-80 years, must not have presented episodes of chronic neck pain for more than 7 days in the last 12 months.

Sponsors

Peking University People's Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
21 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

1. Chronic neck pain subjects Inclusion criteria: * Age 21-80 years old. * People must have experienced neck pain for at least 3 months and have reported a minimal pain level of 30 (pain threshold) on the 0-100 pain numerical rating scale (NRS) in the last 7 days.

Exclusion criteria

* Age under 21 or over 80. * Patients were excluded if they had taken pain medications on the day of the assessment or if they had serious spinal pathologies, such as fractures, tumors or inflammatory diseases, such as ankylosing spondylitis, nerve root compromise confirmed by clinical neurological tests or severe cardiorespiratory diseases. * Those who were pregnant, patients with cancer and those with a cardiac pacemaker were also excluded. 2. Healthy volunteers Inclusion criteria: * Age 21-80 years old. * These participants must not have presented episodes of low back pain for more than 7 days in the last 12 months.

Design outcomes

Primary

MeasureTime frameDescription
Change of pressure pain threshold (PPT)The PPT will be measured before CPT, 30 seconds after the CPT begin, and immediately after CPT.A cold pressor test (CPT) was used to induce pain and trigger the conditioned pain modulation (CPM) response. The conditioned stimulus was immersion of the leg in a bucket of ice water on the side ipsilateral to the most painful neck region. The neck PPT was recorded beginning 30 s after immersion of the leg with two PPT measures for each point. The PPT will be also measured again immediately after CPT.

Secondary

MeasureTime frameDescription
Numerical rating scale for pain (NRS)The patients used this scale to rate the pain intensity of the neck pain before the experiment.The NRS evaluates levels of pain intensity using an 100-point scale (range 0-100), with 0 being classified as no sensation, 30 pain threshold, 100 pain as bad as could be.

Countries

China

Contacts

Primary ContactWeiwei Xia, Ph.D.
weiweixia2016@163.com008613260001978

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026